Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and tolerability of cannabidiol in paediatric patients with epilepsy.

Trial Profile

Efficacy and tolerability of cannabidiol in paediatric patients with epilepsy.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 03 Jan 2018

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Epilepsy
  • Focus Expanded access; Pharmacodynamics
  • Most Recent Events

    • 03 Jan 2018 New trial record
    • 05 Dec 2017 Results assessing effect of Cannabidiol on cortical excitability presented at the 71st Annual Meeting of the American Epilepsy Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top